Paediatric Clinical Trials

Holiday Inn Regents Park Hotel, London UK (March, 25 - 26, 2015)

Paediatric Clinical Trials 2015 returns to London next spring for its 9th annual instalment on 25th and 26th March to review the latest developments in the formation of medicines for children.

Join us as we ask questions such as: What procedures can we follow to limit the number of PIP modifications required? Optimizing patient retention strategies for successful trial development - how do we keep patients on board? How do you apply physiologically based pharmacokinetic modelling to select starting doses in children?

We have worked with an expert panel of speakers such as the MHRA, Paediatric Committee, Novo Nordisk and GSK, to bring to you a packed agenda addressing key topics such as Paediatric Investigation Plan (PIP) strategies, the challenges of a limited patient population, site selection, patient retention, PLUS MUCH MORE!

BENEFITS OF ATTENDING:

• New for 2015 - Join us and hear the MHRA discuss guidelines for pharmacokinetic modelling in paediatric regulatory submissions
• New for 2015 - Listen to GlaxoSmithKline discussing considerations associated with the use of foods and beverages to assist the administration of medicines to children
• The PDCO will review Paediatric clinical trials in the EU; what you should know
• Case studies showcasing breakthroughs in paediatric clinical trials
• Hear key pharmaceutical, biotechnology, regulatory and academic experts share their knowledge to ensure your clinical trials have optimal outcomes
• An overview of the current practices and challenges in designing and preparing for paediatric clinical
  trials and how to get yours right!

KEY SPEAKERS:

• Klaus Rose, CEO, klausrose Consulting - Conference Chairman
• Susan Cole, Senior Pharmacokinetics Assessor, MHRA
• Dr Koenraad Norga, Head of Clinic Paediatric Oncology, Universitair Ziekenhuis Antwerpen, Vice Chairman, Paediatric Commitee (PDCO)
• Dr Mette Due Theilade, Principal Scientist, Paediatric Investigation Plan (PIP), Regulatory Affairs,
  Novo Nordisk A/S
• Dr Cristina De Min, Chief Medical Officer, Novimmune
• Terry Ernest, Formulation Team Manager, Global Formulation, Product Development, GlaxoSmithKline R&D
• Dr Philippe Auby, Vice President of Global Clinical Research, Paediatric Neuro-Psychiatry, Lundbeck

To register or for further information, visit www.paediatric-trials.co.uk.

Alternatively contact the team on +44 (0)870 9090 712 or email events@smi-online.co.uk

Více: www.paediatric-trials.co.uk